Heart Failure
| Overview / Abstract: |
Intended Audience: Pharmacists Heart failure (HF) is a common condition that causes significant disability and death in the US and around the world. About 6.5 million adults in the US have HF – and despite advances in drug and device therapies, HF was a contributing cause of 1 in 8 deaths in 2017.The estimated total cost of HF (including health care, medication and missed work) in 2012 was almost $31 billion.The prevalence of HF continues to rise, and is expected to exceed 8 million people by 2030. By this time, the medical costs of HF management are projected to reach $53 billion annually. This issue describes the physiology underlying different types of HF and reviews all aspects of the medications that are currently available and recommended for its management. Various factors and medications that can worsen HF are also discussed. |
|
Expiration |
Apr 23, 2023 |
|
Discipline(s) |
Pharmacy CPE |
|
Format |
Monograph, Online |
|
Cost |
$6.95 |
|
Credits / Hours |
1.5 |
|
Accreditation |
ACPE |
|
Presenters / Authors / Faculty |
Douglas Jennings, PharmD, FACC, FAHA, FCCP, FHFSA,BCPS is an Associate Professor of Pharmacy Practice at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University, and the clinical pharmacist for the heart transplant and ventricular assist device teams at NewYork-Presbyterian Columbia University Medical Center. |
|
Keywords / Search Terms |
The Rx Consultant Heart, Heart Failure, Heart Attack, HF, Pharmacists, CE, Pharmacology, Rx Consultant |
|